$0.68
+0.08
(+13.33%)▲
Insights on Purple Biotech Ltd
In the last 1 year, Novo Nordisk A/s has given 58.5% return, outperforming this stock by 127.9%
In the last 3 years, Novo Nordisk A/s has given 232.5% return, outperforming this stock by 319.8%
14.56%
Downside
Day's Volatility :16.99%
Upside
2.84%
55.54%
Downside
52 Weeks Volatility :84.73%
Upside
65.66%
Period | Purple Biotech Ltd | Index (Russel 2000) |
---|---|---|
3 Months | -15.49% | 0.0% |
6 Months | -41.18% | 0.0% |
1 Year | -69.39% | 0.0% |
3 Years | -87.15% | -20.1% |
Market Capitalization | 14.7M |
Book Value | $0.14 |
Earnings Per Share (EPS) | -0.9 |
Wall Street Target Price | 9.67 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -28.14% |
Return On Equity TTM | -49.09% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | -120.0K |
EBITDA | -22.2M |
Diluted Eps TTM | -0.9 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.92 |
EPS Estimate Next Year | -0.63 |
EPS Estimate Current Quarter | -0.2 |
EPS Estimate Next Quarter | -0.19 |
What analysts predicted
Upside of 1322.06%
Sell
Neutral
Buy
Purple Biotech Ltd is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Purple Biotech Ltd | 32.33% | -41.18% | -69.39% | -87.15% | -85.74% |
Moderna, Inc. | 37.56% | 83.82% | 13.37% | -12.47% | 553.14% |
Regeneron Pharmaceuticals, Inc. | 10.42% | 24.29% | 32.26% | 98.6% | 210.52% |
Novo Nordisk A/s | 7.9% | 30.89% | 58.53% | 230.87% | 458.51% |
Vertex Pharmaceuticals Incorporated | 10.52% | 25.13% | 30.01% | 109.26% | 156.43% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Purple Biotech Ltd | NA | NA | NA | -0.92 | -0.49 | -0.28 | NA | 0.14 |
Moderna, Inc. | 24.73 | NA | 0.0 | -6.46 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 29.16 | 29.16 | 1.46 | 44.2 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 45.83 | 45.83 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 28.9 | 28.9 | 0.53 | 17.11 | 0.24 | 0.13 | NA | 71.8 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Purple Biotech Ltd | NA | $14.7M | -85.74% | NA | 0.0% |
Moderna, Inc. | Buy | $54.0B | 553.14% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.8B | 210.52% | 29.16 | 29.45% |
Novo Nordisk A/s | Buy | $592.1B | 458.51% | 45.83 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $115.1B | 156.43% | 28.9 | 39.46% |
Armistice Capital, LLC
Wuxi AppTec Co Ltd
Kingswood Wealth Advisors LLC
Morgan Stanley - Brokerage Accounts
Millennium Management LLC
Venture Visionary Partners LLC
kitov pharmaceuticals ltd. is a financial services company located in israel.
Organization | Purple Biotech Ltd |
Employees | 20 |
CEO | Mr. Gil Efron CPA, M.A. |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$0.68
+13.33%
Keyarch Acquisition Corp
$0.68
+13.33%
Connexa Sports Technologies Inc
$0.68
+13.33%
Us Value Etf
$0.68
+13.33%
First Wave Biopharma Inc
$0.68
+13.33%
Global X Msci Next Emerging
$0.68
+13.33%
Fat Projects Acquisition Corp
$0.68
+13.33%
Ishares Intl Div Growth Etf
$0.68
+13.33%
Corsair Gaming, Inc.
$0.68
+13.33%